No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 10,402 | 11,806 | 14,044 | 16,816 | 15,950 | 16,665 | 17,233 | N/A | N/A |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 303 | 510 | 607 | 521 | -928 | -1,390 | 276 | N/A | N/A |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Camlin Fine Sciences Limited, an India-based company headquartered in Mumbai and established in 1931 (originally as Camlin Fine Chemicals Limited until August 2011), is involved in the global research, development, production, and distribution of a diverse range of specialty chemicals, ingredients, and additive formulations. The company offers extensive shelf-life extension solutions under its Xtendra and NaSure brands. These include various antioxidants such as Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, alongside natural alternatives like mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Additionally, its offerings comprise mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Its product line also features aroma ingredients, notably vanillin and ethyl vanillin, as well as nutraceuticals sourced through fermentation and plant extraction processes. Furthermore, Camlin Fine Sciences provides performance chemicals like hydroquinone and catechol, and a selection of downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, and HQEE. These versatile products cater to numerous industries worldwide, encompassing food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemicals, agrochemicals, pharmaceuticals, polymers, dyes and pigments, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplements. The company actively engages in international exports of its goods.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Camlin Fine Sciences Limited (CAMLINFINE.NS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Camlin Fine Sciences Limited, an India-based company headquartered in Mumbai and established in 1931 (originally as Camlin Fine Chemicals Limited until August 2011), is involved in the global research, development, production, and distribution of a diverse range of specialty chemicals, ingredients, and additive formulations. The company offers extensive shelf-life extension solutions under its Xtendra and NaSure brands. These include various antioxidants such as Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, alongside natural alternatives like mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Additionally, its offerings comprise mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Its product line also features aroma ingredients, notably vanillin and ethyl vanillin, as well as nutraceuticals sourced through fermentation and plant extraction processes. Furthermore, Camlin Fine Sciences provides performance chemicals like hydroquinone and catechol, and a selection of downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, and HQEE. These versatile products cater to numerous industries worldwide, encompassing food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemicals, agrochemicals, pharmaceuticals, polymers, dyes and pigments, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplements. The company actively engages in international exports of its goods.
